State Street’s Q32 Bio QTTB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $665K | Buy |
52,214
+10,700
| +26% | +$89.4K | ﹤0.01% | 3526 |
|
|
2026
Q1 | $267K | Buy |
41,514
+20,277
| +95% | +$96.3K | ﹤0.01% | 3822 |
|
|
2025
Q4 | $70.5K | Hold |
21,237
| – | – | ﹤0.01% | 4110 |
|
|
2025
Q3 | $42K | Sell |
21,237
-5,700
| -21% | -$11K | ﹤0.01% | 4176 |
|
|
2025
Q2 | $40.1K | Sell |
26,937
-110,561
| -80% | -$188K | ﹤0.01% | 4124 |
|
|
2025
Q1 | $227K | Buy |
137,498
+21,965
| +19% | +$59.1K | ﹤0.01% | 3794 |
|
|
2024
Q4 | $397K | Buy |
115,533
+5,369
| +5% | +$170K | ﹤0.01% | 3680 |
|
|
2024
Q3 | $4.92M | Buy |
110,164
+28,865
| +36% | +$1.06M | ﹤0.01% | 2980 |
|
|
2024
Q2 | $1.46M | Buy |
+81,299
| New | +$1.95M | ﹤0.01% | 3414 |
|
|
2024
Q1 | – | Sell |
-7,434
| Closed | -$81.4K | – | 4408 |
|
|
2023
Q4 | $81.4K | Hold |
7,434
| – | – | ﹤0.01% | 4095 |
|
|
2023
Q3 | $157K | Hold |
7,434
| – | – | ﹤0.01% | 3996 |
|
|
2023
Q2 | $118K | Hold |
7,434
| – | – | ﹤0.01% | 4184 |
|
|
2023
Q1 | $138K | Hold |
7,434
| – | – | ﹤0.01% | 4207 |
|
|
2022
Q4 | $169K | Hold |
7,434
| – | – | ﹤0.01% | 4174 |
|
|
2022
Q3 | $215K | Sell |
7,434
-73
| -1% | -$2.98K | ﹤0.01% | 4113 |
|
|
2022
Q2 | $266K | Sell |
7,507
-47,544
| -86% | -$1.62M | ﹤0.01% | 4086 |
|
|
2022
Q1 | $3.01M | Buy |
55,051
+8,032
| +17% | +$499K | ﹤0.01% | 3414 |
|
|
2021
Q4 | $3.08M | Sell |
47,019
-647
| -1% | -$62.8K | ﹤0.01% | 3478 |
|
|
2021
Q3 | $6.75M | Buy |
47,666
+7,763
| +19% | +$989K | ﹤0.01% | 3081 |
|
|
2021
Q2 | $5.22M | Buy |
39,903
+1,939
| +5% | +$242K | ﹤0.01% | 3228 |
|
|
2021
Q1 | $6.43M | Sell |
37,964
-1,154
| -3% | -$243K | ﹤0.01% | 2948 |
|
|
2020
Q4 | $7.95M | Sell |
39,118
-826
| -2% | -$160K | ﹤0.01% | 2750 |
|
|
2020
Q3 | $7.69M | Sell |
39,944
-42,110
| -51% | -$9.44M | ﹤0.01% | 2579 |
|
|
2020
Q2 | $22.4M | Buy |
82,054
+35,645
| +77% | +$9.5M | ﹤0.01% | 1960 |
|
|
2020
Q1 | $13M | Buy |
46,409
+894
| +2% | +$274K | ﹤0.01% | 2104 |
|
|
2019
Q4 | $17M | Sell |
45,515
-1,710
| -4% | -$490K | ﹤0.01% | 2256 |
|
|
2019
Q3 | $15.4M | Sell |
47,225
-2,510
| -5% | -$853K | ﹤0.01% | 2225 |
|
|
2019
Q2 | $17.5M | Buy |
49,735
+33,233
| +201% | +$13.1M | ﹤0.01% | 2204 |
|
|
2019
Q1 | $8.24M | Buy |
16,502
+1,267
| +8% | +$566K | ﹤0.01% | 2556 |
|
|
2018
Q4 | $6.13M | Buy |
15,235
+6,948
| +84% | +$2.63M | ﹤0.01% | 2624 |
|
|
2018
Q3 | $3.41M | Buy |
8,287
+657
| +9% | +$223K | ﹤0.01% | 3044 |
|
|
2018
Q2 | $2.8M | Buy |
+7,630
| New | +$2.73M | ﹤0.01% | 3122 |
|
Other funds holding QTTB
S
CG
QC
EWA
SS
State Street's QTTB Position: Q2 2026 in Review
State Street increased its Q32 Bio (QTTB) stake by 26% in Q2 2026, buying an estimated $89.4K and bringing the position to 52,214 shares worth $665K. The position accounts for ﹤0.01% of the portfolio, ranked #3526.
State Street first reported a position in QTTB in Q2 2018 and has held it in 32 quarters since. The position peaked at $22.4M in Q2 2020. 15 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.
- State Street held 52,214 shares of Q32 Bio worth $665K as of Q2 2026.
- State Street bought 10,700 Q32 Bio shares in Q2 2026, an estimated $89.4K.
- Q32 Bio made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3526 holding.
- State Street first reported a position in Q32 Bio in Q2 2018 and has held it in 32 quarters since.
- State Street's Q32 Bio position peaked at $22.4M in Q2 2020.
- 15 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.